[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) filing a Form 144 notifies a proposed sale of 35,000 shares of common stock via E-Trade with an aggregate market value of $555,100, to be sold on 09/08/2025 on the Nasdaq Stock Market. The shares were acquired on 09/12/2022 from the vesting of restricted stock units under the company's 2021 Equity Incentive Plan. The filer also reported prior sales under a 10b5-1 plan on 06/10/2025 (60,000 shares, $876,048) and 06/11/2025 (40,863 shares, $621,207.50). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: This Form 144 reports routine insider sales from vested RSUs and recent 10b5-1 plan activity; amounts are small relative to total shares outstanding.

The filing documents a proposed sale of 35,000 shares valued at $555,100 and prior 10b5-1 sales totaling 100,863 shares in June 2025. The shares to be sold were acquired on 09/12/2022 via RSU vesting. With ~198 million shares outstanding per the filing, the reported transactions represent a de minimis percentage of the share base, suggesting limited direct impact on capitalization or liquidity. The inclusion of the seller's representation about no undisclosed material adverse information is standard and required for Rule 144 notices.

Corporate Governance Expert

TL;DR: Insider sales follow equity plan vesting and 10b5-1 procedures; disclosure appears compliant and routine.

The notice identifies the source of the securities as RSU vesting under the 2021 Equity Incentive Plan and lists a broker for the proposed sale. Prior sales were executed under a 10b5-1 plan, which, if properly adopted, provides a prearranged mechanism for insiders to sell shares. The filing contains the required signer attestation about material nonpublic information. No departures from typical Rule 144 disclosure form are evident in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	35000	555100	198031417	09/08/2025	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/12/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			68177	09/12/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for Robert Scavo 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/11/2025	40863	621207.50
10b5-1 Sales Plan for Robert Scavo 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/10/2025	60000	876048

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Alignment Healthcare's Form 144 for ALHC report?

The Form 144 reports a proposed sale of 35,000 shares valued at $555,100 to be sold on 09/08/2025 on Nasdaq; shares were acquired via RSU vesting on 09/12/2022.

Were there recent insider sales by the filer before this Form 144?

Yes; the filing shows 10b5-1 plan sales on 06/10/2025 of 60,000 shares for $876,048 and on 06/11/2025 of 40,863 shares for $621,207.50.

How were the shares being sold originally acquired?

The shares were acquired on 09/12/2022 through the vesting of restricted stock units granted under Alignment Healthcare's 2021 Equity Incentive Plan.

Which broker is handling the proposed sale in the Form 144?

The broker listed for the proposed sale is E-Trade Finance, PO Box 101600, Arlington VA 22210-4600.

How large is the issuance relative to shares outstanding?

The filing shows 198,031,417 shares outstanding; the proposed 35,000-share sale represents a very small fraction of that total.